Anthropic quietly sets up biology lab as it ramps AI drug program: Report
Anthropic says the lab will support physical biology research and automation, while the company limits access to some models over dual-use risks.
- On Friday, September 18, 2026, Anthropic reported that its Claude model now leads 26% of internal research and development, collaborating with human staff on about 90% of tasks.
- Anthropic CEO Dario Amodei recently called for slowing AI development to address safety concerns, arguing for "better visibility into the pace of AI development" to help the public decide how to use the technology.
- "Models accelerating their own development could make it more challenging for humans to understand or control these systems," Anthropic warned, while researcher Jacob Coxon claimed industry leaders are "racing straight toward self-improving superintelligence."
- Tech leaders including OpenAI CEO Sam Altman and SpaceX CEO Elon Musk have backed calls for regulatory restraint with third-party "embedded evaluators" from METR, though legislative efforts to mandate emergency shutoffs have stalled.
- President Donald Trump dismissed calls for guardrails, arguing that AI development requires only a "STRONG AND SMART PRESIDENT" and claiming efforts to curb domestic AI advancement constitute "a SICK conspiracy" benefiting China.
188 Articles
188 Articles
Anthropic quietly sets up biology lab
SAN FRANCISCO — Anthropic quietly set up a laboratory to do physical biology work as it pushes its artificial intelligence ambitions into the world of drug science.
Anthropic sets up biology lab
MEDICAL RESEARCH
Almost a thousand copies of Claude worked less than a day to find him. In ten more attempts they never saw him again.
According to the company, nearly a thousand copies of Claude working in parallel have screened a base of DNA sequences for 21 hours to perform an analysis that would take weeks or even months to a researcher. These IA agents have noticed, in viruses that attack bacteria, a pattern apparently gone unnoticed so far: short fragments of DNA repeated at regular intervals, next to an enzyme already known and a protein whose role is unknown. This organ…
Coverage Details
Bias Distribution
- 47% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





































